Lobe Sciences Ltd. (CVE:LOBE)

BRIEF

published on 10/14/2026 at 14:05, 1 hour 34 minutes ago

Annette Grimaldi rejoint le conseil d'administration de Lobe Sciences

Nomination Au Conseil D'administration Banque D'investissement Sciences De La Vie Développement Biopharmaceutique Conseil Stratégique
BRIEF

published on 10/14/2026 at 14:05, 1 hour 34 minutes ago

Annette Grimaldi Joins Lobe Sciences' Board of Directors

Life Sciences Investment Banking Board Appointment Biopharmaceutical Development Strategic Advisory
PRESS RELEASE

published on 10/14/2026 at 14:00, 1 hour 39 minutes ago

Lobe Sciences Appoints Annette Grimaldi, Former Head of Life Sciences Investment Banking at BMO Capital Markets, to Board of Directors
Lobe Sciences appoints veteran Annette Grimaldi with 35 years experience as Director, focusing on advancing therapies for unmet needs. Company working on L-130 and S-100 development

Clinical-Stage Biopharmaceutical Lobe Sciences Annette Grimaldi L-130 S-100
BRIEF

published on 10/08/2026 at 14:05, 6 days 1 hour ago

Lobe Sciences annonce des opérations stratégiques sur les marchés financiers

Relations Avec Les Investisseurs Nomination Au Conseil D'administration Marchés Des Capitaux Développement Pharmaceutique L-130 Progrès
BRIEF

published on 10/08/2026 at 14:05, 6 days 1 hour ago

Lobe Sciences Announces Strategic Capital Market Moves

Investor Relations Capital Markets Board Appointment Pharmaceutical Development L-130 Progress
PRESS RELEASE

published on 10/08/2026 at 14:00, 6 days 1 hour ago

Lobe Sciences Announces Proposed Capital Markets Initiatives to Support Planned Growth
Lobe Sciences Ltd. announces plans to enhance capital markets presence with market-making services, investor relations expansion, and new board member appointment to support pharmaceutical programs advancement

Investor Relations Capital Markets Market-making Services Lobe Sciences Ltd. Pharmaceutical Programs
BRIEF

published on 09/15/2026 at 05:05, 29 days 10 hours ago

Lobe Sciences to Showcase Low-Dose Psilocin Data at Summit

Clinical Data Neuropsychiatric Summit L-130 Psilocin Low-dose Therapy Outpatient Use
BRIEF

published on 09/15/2026 at 05:05, 29 days 10 hours ago

Lobe Sciences présentera des données sur la psilocine à faible dose lors du sommet

Données Cliniques Sommet De Neuropsychiatrie L-130 Psilocine Thérapie À Faible Dose Utilisation En Ambulatoire
PRESS RELEASE

published on 09/15/2026 at 05:00, 29 days 10 hours ago

Lobe Sciences to Present Low-Dose L-130 Clinical Data at 9th Neuropsychiatric Drug Development Summit
Dr. Frederick D. Sancilio to present 'Reimagining Psychedelic Therapeutics for Daily Outpatient Use' at the 9th Neuropsychiatric Drug Development Summit on September 16, featuring Phase 1a results for Conjugated Psilocin™ (L-130)

Conjugated Psilocin Lobe Sciences Ltd. Psychedelic Therapeutics Dr. Frederick D. Sancilio Neuropsychiatric Drug Development Summit
BRIEF

published on 09/01/2026 at 01:05, 1 month 13 days ago

Lobe Sciences Ltd. Completes Private Placement Upsize

Private Placement Clinical Trials Biopharmaceutical Lobe Sciences Sickle Cell

Published on 10/14/2026 at 15:00, 39 minutes ago

Route1 Provides Operating and Market Update; Outlines Q4 2026 Priorities
Published on 10/14/2026 at 15:00, 39 minutes ago

Positive Preliminary Results Presented at Annual American College of Gastroenterology Meeting for Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer
Published on 10/14/2026 at 14:50, 49 minutes ago

AIAI Holdings to Present at the 20th Annual LD Micro Main Event
Published on 10/14/2026 at 14:30, 1 hour 9 minutes ago

Boron One Holdings Inc. Announces Positive Preliminary Economic Assessment (PEA) for Its Piskanja Boron Project
Published on 10/14/2026 at 14:30, 1 hour 9 minutes ago

Predictiv AI Launches Flockentis, Bringing Canadian AI Decision Intelligence to Global Fleet and Logistics Operations

View all ACCESSWIRE

Published on 10/14/2026 at 15:05, 34 minutes ago

Precisely Launches MCP Server for Precisely Automate, Connecting AI Assistants to SAP Automation
Published on 10/14/2026 at 15:00, 39 minutes ago

Amrize Announces Date for Third Quarter 2026 Financial Results
Published on 10/14/2026 at 14:47, 52 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 10/14/2026 at 14:46, 53 minutes ago

Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 10/14/2026 at 14:46, 53 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Permanent TSB Group Holdings plc

View all EQS

Published on 10/14/2026 at 10:39, 4 hours 59 minutes ago

Number of shares and voting rights - September 2026 (In French only)
Published on 10/14/2026 at 10:39, 4 hours 59 minutes ago

Nombre total d'actions et droits de vote - septembre 2026
Published on 10/14/2026 at 08:00, 7 hours 39 minutes ago

Kerlink Launches Wirnet™ iEdge Series
Published on 10/14/2026 at 08:00, 7 hours 39 minutes ago

Kerlink lance la gamme Wirnet™ iEdge
Published on 10/13/2026 at 17:45, 21 hours 53 minutes ago

ENGIE and CMA CGM join forces to invest in biomethane production in Le Havre

View all LES ECHOS COMFI WIRE

News